Axon Neuroscience

• NCT07167966

  Collaborator, Phase 2, Enrolling by invitation, 450 people, 11 Sept 2025

• Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies

  Consulting or advice, 8 Sept 2026

• Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study

  Consulting or advice, Fees or honoraria, 3 Sept 2026

• Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease

  Consulting or advice, Fees or honoraria, 1 Sept 2026

• Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome

  Consulting or advice, Fees or honoraria, 1 Sept 2026

• Exploring blood-based biomarkers in late-life depression: Correlates of psychotherapeutic treatment outcomes

  Consulting or advice, Fees or honoraria, 23 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org